Get started
Author

Asma Hadjeb

Observed names: A. Hadjeb, H. Asma
OpenAlex ID: A5088940463
MPN-076 Impact of Comorbidities and Response to Treatment on the MPN SAF Assessment of Philadelphia Chromosome–Negative Myeloproliferative Syndromes
2022 · Amina Ramdoun, Asma Hadjeb, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Pb2058: Impact of Comorbidities and Response to Treatment on the Mpn Saf Assessment of Philadelphia Chromosome Negative Myeloproliferative Syndromes.
2022 · B. Mohamed, H. Asma, et al. · HemaSphere · 1
CML-068 Impact of Low Grade Effects of Tyrosine Kinase Inhibitors on the Quality of Life of Patients Treated for Chronic Myeloid Leukemia
2022 · Sidi Mohamed El Amine Benlazar, Asma Hadjeb, et al. · Clinical Lymphoma Myeloma & Leukemia
Poster: CML-068 Impact of Low Grade Effects of Tyrosine Kinase Inhibitors on the Quality of Life of Patients Treated for Chronic Myeloid Leukemia
2022 · Sidi Mohamed El Amine Benlazar, Asma Hadjeb, et al. · Clinical Lymphoma Myeloma & Leukemia
Poster: MPN-076 Impact of Comorbidities and Response to Treatment on the MPN SAF Assessment of Philadelphia Chromosome–Negative Myeloproliferative Syndromes
2022 · Amina Ramdoun, Asma Hadjeb, et al. · Clinical Lymphoma Myeloma & Leukemia
Predictors Factors of Death during Induction Therapy of Acute Myeloblastic Leukemias (Western Algeria, multicenter experience)
2018 · Brahim Benzineb, Mesli Naima, et al. · Blood
La tuberculose chez les patients traités pour lymphome de Hodgkin
2010 · S.M.A. Benlazar, A. Hadjeb, et al. · Cancer/Radiothérapie
Hémopathies malignes secondaires après traitement des lymphomes hodgkiniens
2010 · S.M.A. Benlazar, A. Hadjeb, et al. · Cancer/Radiothérapie
Néoplasies secondaires après traitement des lymphomes hodgkiniens
2009 · S.M.A. Benlazar, A. Hadjeb, et al. · La Revue de Médecine Interne
P063 Results of LINKER regimen in the treatment of adult acute lymphoblastic leukemia
2007 · M. Benlazar, A. Hadjeb, et al. · Blood Reviews
Works count: 10
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type